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ABSTRACT
Interleukin-1, a mediator of inflammation, or tumor
promoting phorbol esters induce transcription of
stromelysin, a metalloproteinase that degrades
extracellular matrix molecules and that is
overexpressed in diseases such as rheumatoid arthritis.
Sequences required for induction of transcription of the
human stromelysin promoter are contained on a 46
base pair fragment. This fragment contains a sequence
with a high degree of similarity to the binding site for
the transcription factor activator protein-I (AP-1) and
indeed, the AP-1 sequence of this fragment is
necessary but not sufficient for the maximal response
to phorbol 1 2-myristate 13-acetate (phorbol) or
interleukin-1. Maximal induction requires functional
cooperation between the AP-1 sequence and a
neighboring upstream regulatory sequence (URS) of
the stromelysin promoter which is also necessary but
not sufficient. We demonstrate that both the AP-1
sequence and the URS bind phorbol or interleukin-1
induced nuclear proteins. Cooperation of the AP-1
sequence with another sequence present in the
stromelysin promoter may be a general mechanism
whereby the AP-1 element, which is found in many
promoters, achieves a maximal and specific response
to various stimuli.
INTRODUCTION
Interleukin-1 (IL-1) is an inflammatory mediator that is present
in the synovial fluids from a variety of rheumatological diseases
including rheumatoid arthritis (1). These diseases are
characterized by the presence of excess amounts of collagenase
and stromelysin, enzymes that degrade the extracellular matrix
and that are produced predominantly by fibroblasts within the
joint (2). We have studied mechanisms controlling the expression
of stromelysin. Previously we reported that when cultures of
normal human skin fibroblasts are treated with the tumor
promoter phorbol 12-myristate 13-acetate (phorbol) or IL-1,
expression of the mRNA for stromelysin is induced (3). We
demonstrated that this induction is at the level of transcription:
a 307 base pair (bp) fragment of the human stromelysin promoter
linked to the reporter gene chloramphenicol acetyl transferase
(CAT), gave a 4 to 8 fold induction of CAT activity in response
to phorbol or IL-lfl (3). This fragment contains a 9 bp sequence
with 89% identity to the collagenase binding site for the
transcription factor AP-1 (4), which is comprised of several
proteins, some of which are the products of the fos and jun
oncogene families (5). Others have reported that 3 repeats of an
AP-1-like sequence can drive reporter gene expression in a mouse
T lymphoma cell line in response to costimulation with IL-1 and
phytohemagglutinin (PHA) (6), while another inflammatory
mediator, tumor necrosis factor alpha, induces transcription
through 5 tandem copies of the human collagenase AP-1 sequence
in primary fibroblasts (7).
We have focused our studies on the native configuration of
the human stromelysin promoter in which tandem repeating
copies of the AP-1 sequence are not present (3). Here we report
that a 46 bp fragment of the stromelysin promoter (designated
0.OSS), which spans nucleotides -54 to -100 relative to the
transcription start site (8), and which includes an AP-1 sequence
is as responsive to phorbol or IL-1 as the longer promoter
fragment when transiently transfected into normal human foreskin
fibroblasts. Therefore, this fragment contains sequences important
for IL-1 and phorbol regulation. We find that in normal
fibroblasts, a single copy of the AP-1 sequence is not highly
responsive to phorbol or IL-I treatment: both the AP-l sequence
and additional sequences native to the stromelysin promoter are
required for the maximal response. In addition, both regions have
the ability to bind phorbol or IL-1 induced nuclear proteins.
MATERIALS AND METHODS
DNA Manipulations
The synthetic oligonucleotides (oligos) were made on a Biosearch
Cyclone DNA synthesizer. All the oligos contained 5' Hind ml
and 3' Bam HI linkers and were cloned 5' to 3' relative to the
thymidine kinase (TK) promoter driving chloramphenicol acetyl
transferase (CAT) expression in the reporter plasmid pBLCAT2
(9). Cloning of synthetic oligos and DNA sequencing of the
cloned oligos to confirm that the correct sequence was cloned
was performed by standard techniques (10).
Cell Culture
Normal human foreskin fibroblasts were obtained from the
Newborn Nursery at Dartmouth Hitchcock Hospital. Cells were
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grown in Dulbecco's Modified Eagle's Medium with 10% fetal
calf serum, were passaged 1:3 with trypsin, and were used
between passages 6 and 13 as described (3).
DNA Transfection
Each plasmid used for transfection was purified through a cesium
chloride gradient (10). For transfection, 10 /tg of plasmid DNA
and 10 Ag of sheared calf thymus carrier DNA were transiently
cotransfected into 5 x105 fibroblasts in 60 millimeter (mm)
dishes by the calcium phosphate coprecipitation method with
glycerol shock as described (8, 11, 12). After a 24 hour recovery
period in medium containing 10% fetal calf serum, the cells were
washed to thoroughly remove the serum, transferred to serum
free medium, and treated for 24 hours with 10-8 M phorbol or
400 U/mL human recombinant IL-1:3 (a kind gift from Immunex
Corp., Seattle, WA). Cells were harvested as described (13).
RESULTS AND DISCUSSION
Transcriptional Regulatory Regions of the Human
Stromelysin Promoter
To further our understanding of how phorbol or IL-1 induce
transcription, we sought to define the role of specific sequences
contained on the human stromelysin promoter. We assayed the
ability of fragments and mutants of the stromelysin promoter to
drive reporter gene transcription in response to phorbol or IL-1.
Figure 1 shows the sequence of a 46 bp fragment of the
stromelysin promoter (designated 0.05S), spanning nucleotides
-54 to -100 relative to the transcription start site (8). Also
A. HIN STR1IMYSIN SEQUENCZ EZLOT SIMILARITIES
NIP like PEA3 like AP-1 like
GTCCTGCTGCCATTTGGATGAAAGCAAGGATGAGTCAAGCTGCGGGT HuStrom 0 .05S
GATCCTCTCACCTGCTGCCATGCTTCCCAT NIP from Hu IL-3
CAT Assay
CAT activity was measured by assaying percent incorporation
of 14C-chloramphenicol into the acetylated form by liquid
scintillation counting of the appropriate regions of thin layer
chromatography sheets as described (13). All assays were
performed in the linear range and equal amounts of protein were
used for each sample. Each plasmid, from at least two different
plasmid preparations, was tested 3 to 10 times in cells from at
least 3 different individuals. The fold induction of CAT activity
upon treatment with 10-8 M phorbol or 400 U/mL or IL-1,8
was normalized to the small degree of induction observed for
the parental pBLCAT2 vector. Although we have observed that
the magnitude of induction may vary from one batch of cells to
the next, the relative activities of each of the constructs remains
constant.
CAGGAAGT
ATGAGTCAG
PEA3 from polyoma
virus enhancer
AP-1 from Hu Coll
B. OLIGOUUJLZOTIDIS
0 . 05S GTCCTGCTGCCATTTGGATGAAAGC
mtO. 05S
Al AP-1 GTCCTGCTGCCATTTGGATGAAAGC
mntO 05S
A3 URS GTCCTGCTGCCATTT=TGAAAGC
mtO .05S
A4 URS GTCCTGZCCATTTGGATGAAAGC
URS GTCCTGCTGCCATTTGGATGAAA
mtURSA3 GTCCTGCTGCCATTTh=:TGAA6A
mtURSA4 GTCCTI^GCCATTTGGATGAAA
Nuclear Extracts
Nuclear extracts were prepared as described (14) from primary
cultures of normal human foreskin fibroblasts. Cells were grown
to subconfluence, placed in serum free medium for 16 hours prior
to treatment for 2 hours with 10-8 M phorbol or 400 U/mL
IL-1. Each set of extracts (untreated, phorbol, or IL-l treated)
shown in a figure was isolated from the same batch of fibroblasts
at the same time to control for possible variations in levels of
DNA binding proteins between different foreskins or between
different passage numbers.
Gel Mobility Shift Assay
Five yg of nuclear extract from untreated, phorbol, or IL-l treated
fibroblasts was incubated with approximately 1.5 ng of 32p-
labeled double stranded oligo probe (approximately 30,000 counts
per minute, prepared using the Klenow fragment of DNA
polymerase 1), in the presence or absence of 5, 50 or 500 fold
molar excess unlabeled oligo competitors as described (15,16).
The unbound free probe was resolved from the DNA-protein
complexes by electrophoresis through a 4% 29: 1 nondenaturing
acrylamide gel in a buffer containing 45 mM Tris base, 45 mM
boric acid, and 1 mM ethylene diamine tetraacetic acid (EDTA),
pH 8.5, as described (15). The gels were then exposed to Kodak
XAR film at -70°C with intensifying screens for approximately
24 hours. Selected autoradiographs were quantitated by scanning
with a densitometer (E-C Apparatus Corp.) and analyzed using
a Hewlett-Packard 3390-A peak area integrator.
SAP-! GCAAGGATGAGTCAAGCTGCGGG
mtSAP-i
C. REPORTERS
TK Promoter
SW +1
Figure la. DNA sequence of the 46 bp human stromelysin promoter fragment
(HuStrom 0.05S), located -54 to - 100 relative to the transcription start site
(8), compared to sequences in the nuclear inhibitory protein DNA binding sequence
(NIP) of the human IL-3 promoter (Hu IL-3) (23), the polyoma virus enhancer
alpha domain element 3 (PEA 3) sequence (21), and the AP-l binding sequence
from the human collagenase gene (Hu coll) (4). Asterisk (*) indicates conserved
nucleotides between the two sequences being compared. b. DNA sequences of
the synthetic oligonuleotides (oligos) used in this study. The oligos were synthesized
with Hind 111 and Bam HI linkers. The wild type 0.05S, URS and S AP-l oligos
are shown with the mutant oligos listed below. The bases changed in the mutants
are underlined. c. Map of the reporter plasmid used to assay transcriptional activity
of the stromelysin promoter fragments. Single copies of the oligos listed in Figure
lb were cloned 5' to 3' relative to the thymidine kinase (TK) promoter into the
Hind Ill and Bam HI sites of the polylinker of pBLCAT2, a vector that contains
the TK promoter in front of the chloramphenicol acetyl transferase (CAT) gene (9).
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shown are the synthetic oligonucleotides (oligos) containing
deletions and substitutions within this fragment, and the reporter
constructs used to assay their activity.
Figure 2a compares the phorbol or IL-I induced CAT activity
of the full length 0.05S fragment to the activity of deletions of
this fragment. When one copy of the 0.05S fragment is cloned
in front of the thymidine kinase (TK) promoter, phorbol or IL-I
induces CAT activity of the 0.05S construct by an average of
5 fold relative to the TK CAT plasmid without any additional
sequences (the parental pBLCAT2 plasmid is modestly responsive
to phorbol or IL-1 giving a 1.5 to 2.0 fold induction therefore
all the data presented are normalized to the induction of the TK
promoter in the absence of additional sequences). Since the 5
fold induction of the 0.05S construct is the same degree of
induction we previously reported for a 307 bp stromelysin
promoter fragment (3), we conclude that this 46 bp fragment of
the stromelysin promoter contains sequences important for
phorbol or IL-1 induced transcription.
Within the 0.05S fragment is the AP-l-like element (see Figure
1). We made a 23 bp synthetic oligo, representing the 3' half
of the 0.05S fragment which contains the 9 bp AP-l-like site
and flanking nucleotides (S AP-1). Figure 2a shows that one copy
of the S AP-l DNA fragment is modestly responsive to phorbol
or IL-l (an average of 2-3 fold) but clearly indicates that the
additional sequences contained on the 0.05S fragment lead to a
greater phorbol or IL-l response. We term this additional region
the upstream regulatory sequence (URS). Figure 2a also shows
that the URS by itself, like the S AP-l fragment, can confer a
moderate degree of phorbol or IL-1 responsiveness on the TK
promoter (an average of 3 fold), but is not as responsive as the
0.05S fragment. Therefore, in primary cultures of normal human
fibroblasts, a single copy of the AP-l-like sequence is not highly
responsive. Sequences in addition to the AP-1 sequence, native
to the stromelysin promoter and in their normal single copy
configuration, are necessary for the maximal response to phorbol
or IL-1.
We further assayed the role of sequences contained on the
0.05S fragment by constructing mutations in the 0.05S fragment
and by testing the activity of these mutants. Figure 2b shows the
phorbol or IL-1 responsiveness of three mutant fragments relative
to the activity of the wild type (wt) 0.05S fragment. A single
base change in the AP-l-like element, which decreases AP-1
factor binding to the AP-l binding site in the human collagenase
promoter (17), diminished the IL-1 response of the 0.05S
fragment to 35% of the wt activity and diminished the phorbol
response to 55% of the wt activity. Thus the AP-l-like region
is necessary for the maximal phorbol or IL-1 response of the
0.05S stromelysin promoter fragment.
a
7.-
6-
C
c
3.
2-
relative CAT activity: deletions
0.05S
b
S AP-1
plasmid
relative CAT activity: substitutions
0
.)
c
c
Q)0.
0.05S: wt mt Al mt A3 mt A4
plasmid
Figure 2a. Transcriptional activity of the human stromelysin 46 bp promoter
fragment (0.05S) and of the deletions of this fragment. Normal human foreskin
fibroblasts were transiently transfected with the indicated plasmid by the calcium
phosphate method (see Materials and Methods for details). CAT activity was
measured by assaying percent incorporation of 14C chloramphenicol into the
acetylated form. The fold induction of CAT activity upon treatment with 10-8
M phorbol 12-myristate 13-acetate (phorbol) or 400 U/mL of human recombinant
IL-lO was normalized to the small degree of induction observed for the parental
pBLCAT2 vector. b. Transcriptional activity of 3 different mutant 0.05S
stromelysin promoter fragments relative to the activity of the wild type fragment
(0.05S). See the legend to Figure 2a for details.
probe:. S AP-1 -
extract: 1UntI I ----Phorbol--- 11 -----IL-1-.-
Competitor: SAP-1 mtSAP-1 SAP-1 mtSAP-1
amount: 0 0 5x 50x 5x 50x 0 5x 50x 5x 50x
.....
..
free probe
Figure 3. The S AP-1 sequence binds specific phorbol or IL-I inducible nuclear
proteins. Nuclear extracts were made from untreated human foreskin fibroblasts,
or from cells that were treated with 10-8 M phorbol, or 400 U/mL IL-1 as
indicated. Five Ag of nuclear extract was incubated with 32P-labeled double
stranded oligo probe in the presence or absence of 5, 50 or 500 fold molar excess
unlabeled oligo competitors. See Figure 1 for the names and sequences of all
oligos used. The unbound free probe was resolved from the DNA-protein
complexes by electrophoresis through a nondenaturing acrylamide gel. 'Unt'
indicates nuclear extracts from cells that were processed in the same manner as
those from phorbol or IL- I treated cells except for the absence of either inducing
agent. Arrowheads indicate specific complexes referred to in the text. Mobility
shift experiments were performed on at least three different batches of nuclear
extracts prepared from cells from at least two different individuals. Representative
experiments are shown. In all batches of extract that demonstrated an increase
in binding to the S AP-1 probe with phorbol or IL-I treatment, we also saw the
change in the binding pattern on the URS probe with phorbol or IL-1, as explained
in the text.
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Figures 4a., b., c. The URS fonrs several specific DNA-protein complexes including a phorbol or IL-I induced interaction dependent upon the presence of a wild
type NIP-like sequence. See the legend to Figure 3 for details.
Upstream of the AP-1-like sequence, the URS region of 0.05S
fragment contains a region conserved in the stromelysin and
collagenase promoters of the human (4), rat (18), and rabbit (19,
20) genes. The conservation of this region suggests that it may
have an important regulatory function in metalloproteinase gene
expression and for this reason we undertook a mutational analysis
of it. Others have recently shown that this region of the human
collagenase gene has 75% sequence identity to polyoma virus
enhancer alpha domain element 3 (PEA3) (21) and, indeed, it
functions as a PEA3 element (22). The PEA3 element augments
the response of the AP-1 sequence to phorbol or oncogenes in
a fibroblast cell line when the PEA3/AP-I unit is present as a
tetramer in front of a heterologous promoter (22). However, as
shown in Figure 1, the PEA3-like element of the stromelysin
promoter is only 50% identical to the PEA 3 element originally
identified in the polyoma virus enhancer (21) and only 63%
identical to the human collagenase PEA 3-like element (22). We
tested the putative role of this PEA3-like sequence in stromelysin
gene expression by making a three base substitution in the
PEA3-like element in a region which others have shown to be
required for PEA-3 activity (21). This mutation had a moderate
effect on the phorbol or IL-1 response of the 0.05S fragment,
decreasing the induction to approximately 70% of wt activity.
Therefore, while a mutation in the AP-l-like region decreased
the IL-l induced activity to 35% of wt activity, the mutation in
the PEA3-like element reduced IL-1 induction to 70% of wt
activity. We conclude that this region of the stromelysin
promoter, which has only limited sequence identity to the PEA3
element, does not play a major role in IL-1 induction. The
differences between the phorbol induction of each of the mutants
is not as great. The activity of the AP-l-like mutant is decreased
to 55% of wt while that of the PEA3-like mutant is decreased
to 70% of wt activity.
Immediately 5' of the PEA3-like sequence is a sequence with
similarity to the nuclear inhibitor protein (NIP) binding sequence
(23). In the human IL-3 promoter, a protein that is involved in
negatively regulating the human IL-3 promoter binds to this
sequence in activated T cells (23). The portion of the NIP
b -Jrobe
I A r r 4' C
-impetritoi:
a moun -
tree probe
-o"( jp.,-
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b probe.
extract.
competator.
amount,
!.-----------------------SAP 1
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0.05S tOt .055 mtO.5S tOt.05S
Al AP-1 A3 URS A4 URS
C 5 50 500 5 50 5 505 50 500 5 50 500
free probe
free probe
C probe
extract: iUnt -----Phorxi.-------------------
competitor C .05S MtO .05 mtO .5S mtO C5S
Al AP- A3 UPS C4 URPS
amount. 5 53 500 5 0'i0 O '5 05iO 5Q 5uO
Free probe
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extracte
competitor:
amount.
free probe
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0 05S mtO.05S
Al AP-1
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Figures 5a. and b. The sequences contained on the URS do not affect the affinity of the S AP-1 sequence for specific interactions with phorbol or IL-I induced
proteins. See the legend to Figure 3 for details. c. and d. The S AP-1 sequence does not affect the affinity of the URS for specific interactions with phorbol or
IL-I induced proteins. See the legend to Figure 3 for details.
sequence that is highly conserved between the stromelysin and
the IL-3 promoters is also a region of the IL-3 promoter that
is protected from chemical cleavage or DNAse 1 digestion in the
presence of nuclear proteins (23). We made a four base change
in this region of the stromelysin promoter; the mutated bases
included two of the protected G residues of the IL-3 promoter
footprint (23). This mutation in the NIP-like region decreased
the activity of the 0.05S fragment to 30 or 40% of wt phorbol
or IL-1 induced activity. In contrast to its role as a negative
regulatory element in the IL-3 promoter in activated T cells, this
NIP-like sequence appears to function as a positive regulator in
the stromelysin promoter in normal human fibroblasts. An
alternative explanation is that the mutation made a negatively
acting NIP-like sequence a stronger negatively acting element,
thus preventing a strong positive response. However, based on
the above data, the fact that mutating the NIP-like sequence has
no detectable effect on the ability of the URS to compete for
complex formation in untreated extracts (data not shown), and
gel mobility shift data (see below) we favor the first explanation.
Therefore, 0.05S fragment of the stromelysin promoter requires
at least two elements for the maximal response to phorbol or IL-1:
the S AP-1 sequence and the NIP-like sequence of the URS.
Phorbol or IL-1 Induced Nuclear Proteins Interact with
Specific Stromelysin Promoter Sequences
To further delineate the cooperative role of the S AP-1 sequence
and the URS in producing the maximal induction of the 0.05S
fragment in response to phorbol or IL-1, we assayed the ability
of these fragments to bind IL-I or phorbol induced nuclear
proteins from normal human foreskin fibroblasts. We have
observed that the basal level of DNA binding proteins varies from
one batch of nuclear extracts to the next. However, the relative
induction of binding activity with phorbol or IL-I treatment is
fairly constant. Figure 3 shows the nuclear protein complex
formation when the S AP-1 oligo is used as a probe in gel mobility
shift assays. Phorbol treatment leads to a greater amount of shifted
probe compared to extracts from untreated cells. IL-I treatment
also increases the amount of shifted probe relative to extracts
a probe
extract
competitor
amount
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from untreated cells, as well as resulting in the appearance of
a slower migrating complex. Densitometric scanning of several
different experiments indicates a 2 to 3 fold induction of DNA
binding activity upon treatment with phorbol and a 2 to 4 fold
induction with IL-I treatment. Complex formation is specific and
was competed in a dose dependent manner. A 50 fold molar
excess of S AP-1 competitor abolished the phorbol or IL-1
induced shift while an AP-1 sequence with a mutation known
to reduce the affinity for AP-1 protein (mtS AP-1) (17), no longer
competed for binding to wild type S AP-1. Thus, our data show
that a similar mutation in the AP-1-like sequence reduces activity
of the 0.05S fragment in transfection assays and prevents binding
of phorbol or IL- I induced nuclear proteins in gel mobility shift
assays.
To assay the ability of the URS to bind specific nuclear
proteins, the experiments in Figure 4 were performed. Phorbol
or IL-I treatment leads to a change in the nuclear protein binding
pattern on the URS probe compared to extracts from untreated
cells. The top band is present in all extracts, the middle band
is dominant in the untreated extracts, while the bottom band
appears predominantly in phorbol or IL-l extracts. Densitometric
scanning of several different experiments indicates that the middle
band is twice as intense in extracts from untreated cells compared
to those from phorbol or IL-I treated cells, while the bottom band
is induced 2 fold in phorbol or IL-1 extracts compared to those
from untreated cells. In extracts from either phorbol or IL-1
treated fibroblasts, all the bands were competed by a 50 fold
molar excess of the URS oligo while an unrelated oligo, the S
AP-1 sequence, did not compete at this concentration. (See
Figures 4a and b). These findings indicate that the proteins are
interacting with the URS in a sequence specific manner. Figures
4a and b also show that an oligo with a mutation in the PEA3-like
sequence of the URS (mtURSA3) had a reduced ability to
compete for the formation of the top band in phorbol or IL-1
extracts, while it was still able to compete the bottom band. In
fact, an oligo containing the PEA3 sequence from the polyoma
virus enhancer (py PEA3) had a limited ability to compete the
top band in IL-1 extracts while this effect was less pronounced
in phorbol extracts. Since the top band is present in approximately
the same amounts in extracts from untreated, phorbol, or IL-1
treated cells, and since the 0.05S fragment containing the
PEA3-like mutation is still quite responsive to phorbol or IL-1,
it is likely that the PEA3-like region of the URS has a limited
role in phorbol or IL-1 regulation of the 0.05S fragment.
However, we cannot rule out the possibility that even though
the mutation in the PEA3-like sequence disrupts complex
formation on the URS, it is not a functional mutation in a
sequence required for induction.
Figure 4c shows that an oligo with a mutation in the NIP-like
sequence (mtURSA4) was still able to compete the top band in
phorbol or IL-l extracts. However, this mutant had a decreased
ability to compete for bottom band formation compared to
competitions with the wild type URS. The observed selective
competition by the mutant oligos was confirmed by densitometric
analysis. Therefore, there is a correlation between phorbol or
IL- I induced binding and phorbol or IL- I induced activity of the
0.05S fragment involving the NIP-like sequence.
Characterization of the Protein-DNA Interactions on the
Stromelysin Promoter Fragment
To begin to determine how the URS and S AP- 1 sequence are
cooperating, we tested whether the URS affects the affinity of
the S AP-l sequence. Figures 5a and b indicate that a 50 fold
molar excess of the 0.05S oligo abolished phorbol or IL-l induced
complex formation on the S AP- 1 oligo and a mutation in the
PEA3-like region (mtO.05SA3) or the NIP-like region
(mtO.05SA4) had no detectable effect on the ability of the 0.05S
fragment to compete. As expected, a mutation in the S AP-l
region (mtO.05SA1) significantly diminished the ability of the
0.05S oligo to compete for complex formation on the S AP-1
oligo. Therefore, neither the PEA3-like region nor the NIP-like
region have a detectable effect on the affinity of phorbol or IL-l
induced proteins for the S AP-1 sequence.
The experiments in Figures 5c and d were performed to find
out if the S AP-l sequence affects the affinity of the URS. Figure
Sc and d show that a mutation in the S AP-1 (mtO.05SA1)
sequence had no effect on the ability of the 0.05S oligo to compete
for binding to the URS probe in extracts from phorbol or IL-1
treated cells. Therefore, the S AP-l sequence does not affect the
affinity of phorbol or IL-l induced nuclear proteins for the URS.
As expected from the results in Figure 4, a mutation in the
PEA3-like sequence (mtO.05SA3) decreased the ability of the
0.05S oligo to compete for formation of the top complex from
IL- I extracts on the URS. We note that this mutation had a small
effect in phorbol extracts, and allowed the 0.05S fragment to
compete the bottom complex of IL-1 extracts better than the wt
0.05S oligo. Reasons for these potentially interesting observations
are presently unclear. However, similar to Figure 4, a mutation
in the NIP-like sequence (mtO.05SA4) reduced competition for
the bottom band in phorbol or IL-1 extracts.
CONCLUSIONS
Our data demonstrate that a 46 bp fragment of the stromelysin
promoter (0.05S) is important for phorbol or IL-1 induced
transcription. Further, we have defined elements within this
fragment necessary for the response to these agents. The
AP-1-like sequence is necessary but not sufficient for the maximal
response and similarly, a sequence element contained on the URS,
the NIP-like sequence of the stromelysin promoter, is also
necessary but not sufficient for the maximal induction of the 0.05S
fragment. Both the NIP-like region and the AP-l-like sequence
are involved in binding phorbol or IL-I induced nuclear proteins.
The AP-l-like sequence and the NIP-like sequence cooperate, not
through a detectable cooperative binding mechanism (see Figure
5), but either in an additive manner or through protein-protein
interactions that increase the transactivating potential of the
proteins bound to the 0.05S human stromelysin promoter
fragment in response to phorbol or IL- 1. In addition, a sequence
that functions as a negative regulatory element in the human IL-3
promoter in activated T cells, seems to function as a positive
regulator in the human stromelysin promoter when transfected
into primary human fibroblasts.
AP-1 sequences are found in the promoters of many genes
including human (4) and rabbit (20) collagenase and human IL-3
(23). In the human (22) and rabbit (Auble and Brinckerhoff,
submitted) collagenase promoters, the PEA3 element and the
AP- 1 element functionally cooperate to provide the maximal
response to phorbol. The human collagenase PEA3/AP-1 unit
also drives transcription in response to the expression of
oncogenes (22). In the IL-3 promoter, multiple elements,
including an AP-1 sequence and the NIP element, cooperate to
respond to phorbol in activated T cells (23). The human
stromelysin promoter is also an example of a promoter that
requires both an AP- 1 sequence and another element(s) for the
transcriptional response characteristic of endogenous gene
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expression. It is possible that cooperation of the AP-1 element
with other elements may provide a general mechanism whereby
the AP-1 sequence is modulated to specifically and maximally
respond to many different stimuli.
Interestingly, there is not a detectable significant difference
between phorbol or IL-1 sequence requirements or in mobility
shift banding patterns on the stromelysin promoter fragment. It
is possible that different DNA binding proteins with the ability
to give the same mobility shift pattern are involved. However,
the similarities suggest that the signal transduction pathways of
tumor promoting phorbol esters and inflammatory mediators such
as IL-I converge on the same transcriptional regulatory elements
with the involvement of similar if not identical DNA binding
proteins.
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